-
Ruxolitinib phosphate: JAK/STAT Assay Workflows
2026-08-20
Build more informative pathway studies with Ruxolitinib phosphate, a selective JAK1/JAK2 tool for cytokine signaling inhibition, inflammatory models, and cancer research. This guide translates recent anaplastic thyroid carcinoma findings into practical assay design, controls, optimization steps, and troubleshooting strategies.
-
LNP Trafficking, Endosomal Entrapment, and Escape
2026-08-20
This study shows that lipid nanoparticle delivery depends not only on cellular uptake but also on where nanoparticles accumulate along the endolysosomal pathway. By combining sensitive LNP labeling with controlled endolysosomal states, the authors identify peripheral endosome entrapment as a barrier to trafficking and suggest that perinuclear lysosomal compartments can support productive cytosolic release.
-
Forskolin and the Translational Logic of cAMP Control
2026-08-19
Forskolin is more than a routine cAMP reagent: as a direct adenylate cyclase activator, it can help translational researchers separate pathway responsiveness from model-specific trafficking, differentiation, and inflammatory effects. This article connects Forskolin biology with recent CFTR trafficking findings and provides a practical framework for rigorous cross-model validation.
-
Vorinostat and mRNA Lipoplex Protein Expression
2026-08-19
Tang and Hattori examined whether the histone deacetylase inhibitor vorinostat alters protein production after firefly luciferase mRNA lipoplex delivery. Low-dose vorinostat enhanced expression in HeLa and HepG2 cells, whereas its effects on tissue distribution and luciferase output after intravenous administration in mice were limited and context-dependent.
-
Camostat Mesilate and Translational Inhibition Logic
2026-08-18
A mechanistic and strategic guide to using Camostat Mesilate across ENaC biology, plasmin–TGF-β signaling, hepatic fibrosis models, and assay-informed translational research—while distinguishing protease inhibition from structure-guided antiviral PPI design.
-
Osteoblast ECM1 and Enzalutamide Resistance
2026-08-18
The reference study identifies osteoblast-derived ECM1 as a microenvironmental driver of enzalutamide resistance in bone metastatic prostate cancer. It connects ECM1 to ENO1 phosphorylation, GRB2/SOS1 recruitment, and MAPK activation, while showing that ECM1 or ENO1 inhibition can restore anti-androgen sensitivity.
-
Oltipraz Workflows for Nrf2 and MASLD Research
2026-08-17
Build a controlled Nrf2 induction workflow with Oltipraz to connect phase II enzyme responses with autophagy, ferroptosis, lipid stress, and liver injury readouts. The defined small molecule complements complex botanical interventions by making concentration, timing, and pathway attribution easier to test.
-
X-Gal Workflows for Cloning and Reporter Validation
2026-08-17
Use X-Gal as a fast visual checkpoint for blue-white colony screening, plasmid quality control, and qualitative β-galactosidase reporter workflows. This guide connects practical molecular cloning decisions with findings from olfactory receptor research while clearly separating established use from exploratory assay design.
-
Azithromycin B1398: Reliable Assay Design
2026-08-16
Azithromycin B1398 supports controlled bacterial infection research, resistance testing, and carefully interpreted viability workflows. This scenario-based guide explains mechanism, solvent compatibility, concentration selection, data interpretation, and practical supplier evaluation.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflows
2026-08-15
Pair direct Cy5 visualization with Firefly Luciferase output to separate delivery, intracellular trafficking, and protein expression in one experiment. This practical guide shows how to use a Cap1-capped, 5-moUTP modified mRNA reporter to optimize carriers, compare transfection conditions, and interpret discordant fluorescence and bioluminescence signals.
-
Spatial Disease Defense in Ambrosia Beetle Nests
2026-08-14
Masoudi, Joseph, and Keyhani show that spatial organization and fungal antagonism can buffer disease transmission in social ambrosia beetle colonies. Their findings suggest that nest location, contact structure, brood placement, and microbial interactions jointly protect colony reproduction even when an insect-pathogenic fungus is present.
-
Social Nest Architecture Limits Beetle Disease Spread
2026-08-14
A 2025 iScience study shows that spatial organization within Xyleborus affinis nests can limit fungal disease exposure to brood, even when infected adults remain in close contact with nestmates. The work combines infection experiments, spatial mapping, colony-performance measurements, and fungal interaction assays to identify nest structure and a Neocosmospora symbiont as complementary defenses.
-
Vitamin C in HEV Organoid Assay Design
2026-08-13
Use Vitamin C (ascorbic acid) as a controlled redox and cytotoxicity perturbation in multilineage organoids, while keeping its established anticancer evidence separate from emerging antiviral questions. This workflow connects CT26 tumor assays with liver, intestinal, and brain organoid models to improve dose selection, endpoint interpretation, and troubleshooting in cancer research and HEV studies.
-
MG-132 Workflows for Proteostasis and p53 Studies
2026-08-13
Use MG-132 (Z-LLL-al) to connect acute proteasome blockade with protein accumulation, oxidative stress, apoptosis, and cell-cycle phenotypes. This workflow also shows how to use the compound as a functional perturbation when studying the MLF2–USP7–p53 axis in colorectal cancer models.
-
FAISL Stabilizes FAK in Triple-Negative Breast Cancer
2026-08-12
This study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis, thereby promoting triple-negative breast cancer adhesion, survival, progression, and metastasis. Its combination of transcriptomic discovery, RNA–protein interaction analysis, mechanistic proteolysis assays, and nanoparticle-mediated RNA interference establishes FAISL as a potentially actionable regulator of FAK signaling.